Cannabidiol as an immune modulator: A comprehensive review
Saudi Pharmaceutical Journal · 2025-06 · 33 (3)
DOI: 10.1007/s44446-025-00005-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 23.05.2025. Verfasst von Khizra Mujahid und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chonnam National University, Gwangju, South Korea. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Cannabidiol (CBD), a non-psychoactive phytocannabinoid derived from Cannabis sativa, has emerged as a promising therapeutic agent due to its diverse pharmacological properties, including potent anti-inflammatory, neuroprotective, and immunomodulatory effects. CBD modulates immune responses, including the regulation of T cell activity, induction of macrophage apoptosis, suppression of pro-inflammatory cytokines, and modulation of signaling pathways involved in inflammation and immune homeostasis. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases to identify relevant preclinical and clinical studies on CBD's immunomodulatory effects. Preclinical and clinical studies demonstrate its efficacy in treating autoimmune diseases such as Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, along with its potential in neuropathic pain and cancer therapy. Recent advancements in nanotechnology-based delivery systems have further enhanced CBD's therapeutic potential by improving its solubility, bioavailability, and targeted delivery, enabling innovative approaches for wound healing, inflammation management, and cancer treatment. However, challenges such as variability in immune responses, limited long-term safety data, and potential drug-drug interactions persist. This review comprehensively examines CBD's pharmacokinetics, pharmacodynamics, and immunomodulatory mechanisms, highlighting its clinical potential, existing limitations, and future directions in advancing its integration into precision medicine and immune regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Chonnam National University, Gwangju, South Korea.
- Department of Pharmacology, Faculty of Pharmacy, Bahauddinaq , Zakariya University, Multan, Pakistan.
- Institute of Research and Advanced Studies of Pharmacy (IRASP), Multan, Pakistan.
- College of Pharmacy, Chonnam National University, Gwangju, South Korea. namj@jnu.ac.kr.
- Department of Pharmacology, Faculty of Pharmacy, Bahauddinaq , Zakariya University, Multan, Pakistan. imran.ch@bzu.edu.pk.
Zitieren
APA
Mujahid, K., Rasheed, M. S., Sabir, A., Nam, J., Ramzan, T., Ashraf, W., & Imran, I. (2025). Cannabidiol as an immune modulator: A comprehensive review. Saudi Pharmaceutical Journal, 33(3). https://doi.org/10.1007/s44446-025-00005-7
Vancouver
Mujahid K, Rasheed MS, Sabir A, Nam J, Ramzan T, Ashraf W, et al. Cannabidiol as an immune modulator: A comprehensive review. Saudi Pharmaceutical Journal. 2025;33(3). doi:10.1007/s44446-025-00005-7
BibTeX
@article{Mujahid2025,
author = {Mujahid, Khizra and Rasheed, Muhammad Shahzaib and Sabir, Azka and Nam, Jutaek and Ramzan, Talha and Ashraf, Waseem and Imran, Imran},
title = {Cannabidiol as an immune modulator: A comprehensive review},
journal = {Saudi Pharmaceutical Journal},
year = {2025},
volume = {33},
number = {3},
doi = {10.1007/s44446-025-00005-7}
}
EUVIMED